Abbott signals device sales recovery as hospital staff shortages ease
By Leroy Leo and Khushi Mandowara (Reuters) -Abbott Laboratories said on Wednesday delayed non-urgent surgeries had resumed globally three years into the COVID-19 pandemic as hospital staff shortages eased and customers became regular with health check-ups, sending its shares up 5%. The much-awaited recovery in elective surgeries led the company to effectively raise forecast for…
